Pharma major Dr Reddy's Laboratories has announced its second quarter results of FY11. It has reported net profit at Rs 220 crore as against Rs 197 crore, a growth of 11.68% on year-on-year basis (YoY).
Net sales jumped 19.11% to Rs 1,278 crore from Rs 1,073 crore.
The company's trailing 12-month (TTM) EPS was at Rs 51.01 per share (June, 2010). The stock's price-to-earnings (P/E) ratio was 31.69. The latest book value of the company is Rs 349.57 per share.
At current value, the price-to-book value of the company was 4.62. The dividend yield of the company was 0.7%.
The stock's price-to-earnings (P/E) ratio stands at 31.55 on (NSE).
Source : www.moneycontrol.com
Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
No comments:
Post a Comment